Real-World Efficacy And Safety Of Peptide Receptor Radionuclide Therapy (Prrt) In Gastroenteropancreatic Neuroendocrine Tumors (Gep-Nets).
JOURNAL OF CLINICAL ONCOLOGY(2021)
Abstract
364Background: PRRT with 177Lu-Dotatate (Lutathera) is a radiolabeled somatostatin analog indicated treatment of somatostatin receptor (STTR) positive GEP-NETs. The study aims to establish the effi...
MoreTranslated text
Key words
peptide receptor radionuclide therapy,gastroenteropancreatic neuroendocrine tumors,neuroendocrine tumors,real-world,gep-nets
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined